Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats (2008)
- Authors:
- USP affiliated authors: SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; BENDHACK, LUSIANE MARIA - FCFRP ; GERLACH, RAQUEL FERNANDA - FORP
- Unidades: FMRP; FCFRP; FORP
- DOI: 10.1016/j.ejphar.2008.10.007
- Subjects: DIABETES MELLITUS; METALOPROTEINASES; DOENÇAS CARDIOVASCULARES; ESTRESSE OXIDATIVO
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: European Journal of Pharmacology
- ISSN: 0014-2999
- Volume/Número/Paginação/Ano: v. 599, n. 1-3, p. 110-116, 2008
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MARTINEZ, Marcio L. L. et al. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, v. 599, n. 1-3, p. 110-116, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ejphar.2008.10.007. Acesso em: 23 abr. 2024. -
APA
Martinez, M. L. L., Rizzi, E., Castro, M. M., Fernandes, K., Bendhack, L. M., Gerlach, R. F., & Tanus-Santos, J. E. (2008). Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats. European Journal of Pharmacology, 599( 1-3), 110-116. doi:10.1016/j.ejphar.2008.10.007 -
NLM
Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007 -
Vancouver
Martinez MLL, Rizzi E, Castro MM, Fernandes K, Bendhack LM, Gerlach RF, Tanus-Santos JE. Lercanidipine decreases vascular matrix metalloproteinase-2 activity and protects against vascular dysfunction in diabetic rats [Internet]. European Journal of Pharmacology. 2008 ; 599( 1-3): 110-116.[citado 2024 abr. 23 ] Available from: https://doi.org/10.1016/j.ejphar.2008.10.007 - Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
- Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension
- Evaluation of aortic metalloproteinase-2 (MMP-2) activity in two kidney one clip (2K1C) hypertension rats
- Metalloproteinase inhibition ameliorates hypertension and reverses vascular dysfunction and remodeling in renovascular hypertensive rats
- Increased activity of matrix metalloproteinase-2(MMP-2) induced by reactive oxygen species (ROS) in two-kidney one-clip (2K1C) hypertension
- Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability
- Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats
- Intraluminal administration of matrix metalloproteinase 2 (MMP-2) increases vascular oxidative stress and the vasoconstriction induced by phenylephrine in rabbit aortic rings
- Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism
- Inibição de metaloproteinases (MMPs) com Doxycycline atenua a embolia pulmonar aguda (EPA)-indutor de hipotensão sistêmica
Informações sobre o DOI: 10.1016/j.ejphar.2008.10.007 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
